Mixed signals about the direction of healthcare reform, payment models, and policy decisions have characterized much of the past year. Given the number of highprofile personnel changes in the Trump Administration, the lack of continuity isn’t surprising.
In recent days, however, the Centers for Medicare & Medicaid Services (CMS) has announced some new initiatives that may make patients’ and healthcare providers’ lives easier:
• MyHealthEData, a program to give patients electronic access to their health records from the device or application of their choice
• Blue Button 2.0, a secure way for Medicare beneficiaries to access and share their personal health data in a universal digital format
• an overhaul of meaningful use requirements, which is intended to reduce time and compliance costs related to the program
• $30 million in grant funding to develop new quality measures for the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
Through this funding, CMS plans to collaborate with clinicians, patients, and other stakeholders to improve healthcare delivery.
“The CMS Quality Measure Development Plan provides a strategy for filling clinician and specialty area measure gaps,” writes Kate Goodrich, MD, director, CMS Center for Clinical Standards and Quality and CMS chief medical officer, in a blog. Gap areas include orthopedic surgery, pathology, radiology, mental health and substance use conditions, oncology, palliative care, and emergency medicine.
Though the efficacy of such initiatives is unknown, their objectives reflect a commitment by CMS to shore up a troubled system. And there are hints that the government may be leaning more toward value-based care (VBC) than in the past.
Cancellation of Medicare’s mandatory episode payment models and the cardiac rehabilitation payment incentive payment model that would have started this year seemed to slow the momentum for moving away from fee-for-service payment. But at the recent Federation of American Hospitals Public Policy Conference & Business Exposition, Health and Human Services Secretary Alex Azar expressed the administration’s support for value: “There is no turning back to an unsustainable system that pays for procedures rather than value. We want to look at bold measures that will fundamentally reorient how Medicare and Medicaid pay for care and create a true competitive playing field where value is rewarded handsomely.”
While hardly a policy statement, Azar’s remarks suggest that organizations that have invested in VBC may not have done so in vain—although they are still in the minority, according to results of the 2018 HealthLeaders Media Annual Industry Outlook Survey.
This online survey of 110 healthcare executives confirmed that the shift to VBC is still slow, with just 19% of net patient revenue value based vs 74% based on fee for service.
Of respondents who have adopted VBC, 59% report some positive return on investment (ROI), with 34% stating it has been strong or moderate over the past 5 years, and 26% report receiving no ROI as of yet.
A survey from the Healthcare Financial Management Association (HFMA), sponsored by Humana, also showed mixed results. The survey of 117 senior financial executives found 74% had positive financial results from VBC vs 26% who reported unfavorable results.
According to the HealthLeaders Media survey, organizations trying to transition to VBC are stymied by:
• inadequate payer incentives (56% of respondents)
• inadequate risk-based contracting models (43%)
• revenue stream uncertainty (36%).
Investing in staffing and infrastructure is considered key for a successful transition. The greatest staffing need will be care coordinators (say 65% of respondents), followed by data analytics staff (46%), nursing staff (43%), and physician staff (42%).
In terms of information technology, respondents ranked clinical analytics as the leading area of investment over the next 3 years (65% of respondents), followed by electronic health record interoperability (49%), mobile health and mobile technology (44%), financial analytics (42%), and data-driven knowledge of patient health factors (40%).
Most financial executives responding to the HFMA survey saw several “readiness gaps” in terms of what would be needed to shift to VBC in the next 3 years. Their biggest concerns were external interoperability (33% of respondents) and internal interoperability (32%), followed by chronic care management (23%).
The HFMA survey also indicates that, since 2015, the percentage of commercial payers using value-based criteria has increased from 12% to 24%. That growth rate is slower than the 50% projected for 2018 back then. Will it approach 75% by 2020?
According to David Wildebrandt, MHA, managing director for Berkeley Research Group, LLC, commercial carriers want the majority of their contracts to be value based by 2020. He urged attendees at the 2018 OR Business Management Conference to plot a 5-year roadmap to transition to value-based care (cover story).
Change takes time, and progress has been slow. But if CMS moves forward with its initiatives, maybe the pace will pick up, and providers and patients alike will reap the rewards. ✥
Castelluci M. Interoperability is biggest barrier to value-based payment adoption, hospital execs say. Modern Healthcare. February 14. 2018.
Dickson V. Verma: Meaningful-use overhaul is coming. Modern Healthcare. March 6, 2018.
HealthLeaders Media. Intelligence Report. Annual Industry Outlook: Exploring Investments and ROI. January-February 2018. www.healthleadersmedia.com/intelligence.
https://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-sheets/2018-Fact-sheets-items/2018-03-06.html.